Custom Peptide Services

Date: October 27, 1997 Comparison chart Chart 2 For years, peptides were the purview of immunologists and endocrinologists, but with the development of combinatorial chemistry and phage display libraries, the demand for peptides has skyrocketed. So too has the number of companies that provide custom peptide services. Once the bailiwick of a handful of companies, the field has burgeoned to close to 40 companies. The playing field is divided into at least two sectors: those companies with lon

Written byLaura Defrancesco
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Date: October 27, 1997 Comparison chart Chart 2
For years, peptides were the purview of immunologists and endocrinologists, but with the development of combinatorial chemistry and phage display libraries, the demand for peptides has skyrocketed. So too has the number of companies that provide custom peptide services. Once the bailiwick of a handful of companies, the field has burgeoned to close to 40 companies. The playing field is divided into at least two sectors: those companies with long-standing traditions in this area that provide comprehensive services in the manufacture and in some cases design and testing of peptides, and those that provide a low-cost product with a quick turnaround to appeal to the impatient and somewhat less discriminating researcher.

What sets companies apart is the range of services provided along with the peptide. Some companies try to be full-service providers with, for example, capabilities for antibody production or oligo production ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies